Product NDC: | 0469-1602 |
Proprietary Name: | Vaprisol |
Non Proprietary Name: | conivaptan hydrochloride |
Active Ingredient(s): | 20 mg/100mL & nbsp; conivaptan hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0469-1602 |
Labeler Name: | Astellas Pharma US, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021697 |
Marketing Category: | NDA |
Start Marketing Date: | 20081008 |
Package NDC: | 0469-1602-10 |
Package Description: | 1 CONTAINER in 1 CARTON (0469-1602-10) > 100 mL in 1 CONTAINER |
NDC Code | 0469-1602-10 |
Proprietary Name | Vaprisol |
Package Description | 1 CONTAINER in 1 CARTON (0469-1602-10) > 100 mL in 1 CONTAINER |
Product NDC | 0469-1602 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | conivaptan hydrochloride |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20081008 |
Marketing Category Name | NDA |
Labeler Name | Astellas Pharma US, Inc. |
Substance Name | CONIVAPTAN HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/100mL |
Pharmaceutical Classes | Antidiuretic Hormone Antagonists [MoA],Vasopressin Antagonist [EPC] |